Benlysta is a human monoclonal antibody that was approved for the treatment of lupus in adults by the U.S. Food and Drug Administration (FDA) in 2011 and for lupus nephritis in adults in 2020.
GSK today announced results from BLISS-SC, a 52-week study for BENLYSTA (belimumab) for subcutaneous use (SC) in adult patients with active, autoantibody-positive systemic lupus erythematosus (SLE) ...
Benlysta (belimumab) is a prescription medication that treats lupus nephritis and systemic lupus erythematosus by weakening the immune system, which can increase infection risk. Common side effects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results